Use of sulbutiamine to obtain pharmaceutical compositions which are useful in the treatment of some psychomotor and psychointellectual disorders
CA 2217463 C · Owner: Les Laboratoires Servier · Inventors: Perret, Laurent; Le Ridant, Alain; Ollat, Helene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of sulbutiamine to obtain pharmaceutical compositions which are useful in the treatment of some psychomotor and psychointellectual disorders observed in patients with Parkinson's disease schizophrenic deficits, alcoholism, major depression and dysthymia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 2, 1997 and granted April 1, 2003. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 2, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 2, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.